TRATAMIENTO DE LA HEPATITIS C CRONICA EN PACIENTES EN RIESGO DE PADECER ENFERMEDADES PSIQUIATRICAS
Columnista Experta de SIIC Schaefer, Martin
en colaboración con
Primera edición en siicsalud:
14 de abril, 2005
Sección Artículos originales,
subsección
Expertos de Iberoamérica,
página
/des/expertocompleto.php/69779
Especialidad principal:
Farmacología
Salud Mental
Especialidades relacionadas:
Medicina Farmacéutica,Medicina Interna,
Schaefer M, Schmidt F, Horn M, Schmid-Wendtner MH, Volkenandt M. Depression during treatment with interferon-alpha, Psychosomatics 45(45):176
Schaefer M, Schwaiger M, Pich M, Lieb K, Heinz A. Neurotransmitter changes by interferon-alpha and therapeutic implications, Pharmacopsychiatry 36(36):S255-258
Schaefer M, Schmidt F, Folwaczny C, Lorenz R, Martin G, Schindlbeck N, Heldwein W, Soyka M, Grunze H, Koenig A, Loeschke K. Treatment of chronic hepatitis C with Interferon-a and ribavirin in patients with a psychiatric disorder, methadone substitution or former drug addiction, Hepatology 37:443-451
Schaefer M, Schmidt F, Neumer R, Scholler G, Schwarz M. Interferon-alpha, cytokines and possible implications for mood disorders, Bipolar Disorder 4 (Suppl 1:111-113
Schaefer M, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Schmidt F, Grunze H, Lieb K. Interferon alpha and psychiatric syndromes: a review, Prog Neuropsychopharmacol Biol Psychiatry 26:1-16, 2003
Schaefer M, Boetsch T, Laakmann G. Psychosis in a methadone substituted patient during interferon-alpha treatment of hepatitis C, Addiction 95:1101-1104
Schaefer M, Schmidt F, Grunze H, Amann B, Schlösser S, Loeschke K. Adding low-dose antidepressants to interferon-alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis, Neuropsychobiology 42 (suppl:43-45
Schaefer, Martin
